Community Development Block Grant COVID (CDBG-CV) funding was allocated to Seminole County Government through the U.S. Department of Housing and Urban Development (HUD) in order to be responsive in preparing, preventing and responding to coronavirus and its impact on people at risk.
As a response to the coronavirus, $900,000 is being awarded to Central Florida Family Health Center d/b/a True Health for monoclonal antibody infusion treatments. Monoclonal antibody infusion is a new emergency treatment available to those with mild to moderate COVID-19 symptoms, who are at higher risk of worsening conditions. This treatment utilizes the medication Regeneron. Eligibility criteria:
- Patient must be homeless, uninsured and/or underinsured
- Patient must be COVID-19 positive, within first 10 days with mild to moderate symptoms and meet one of the criteria below:
o ≥65 years of age
o Overweight – Adults with BMI >25
o Pregnant
o Adults who have any of the following:
Chronic kidney disease, Diabetes, Immunosuppressive disease or treatment, Sickle cell disease, Cardiovascular disease congenital health disease, hypertension, Chronic lung diseases, COPD, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis, pulmonary hypertension, Neurodevelopmental disorders, cerebral palsy, genetic or metabolic syndromes, severe congenital anomalies, medical-related technological dependence (tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19)
Most patients treated with monoclonal antibody IV infusion report an improvement in symptoms within 24 hours. Research shows that receiving this infusion will also lessen the risk of hospitalizations and decrease the risk of mortality.